VEA
APLT

Virtus ETF Advisers’s Applied Therapeutics APLT Stock Holding History

Virtus ETF Advisers’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,524
Closed -$149K – 469
2024
Q3 		$149K Buy
17,524
+314
+2% +$1.85K 0.07% 327
2024
Q2 		$80.4K Buy
+17,210
New +$81.4K 0.04% 406
2021
Q4 		– Sell
-8,790
Closed -$146K – 379
2021
Q3 		$146K Sell
8,790
-457
-5% -$7.89K 0.06% 346
2021
Q2 		$192K Sell
9,247
-3,191
-26% -$60.4K 0.08% 364
2021
Q1 		$233K Buy
12,438
+222
+2% +$4.79K 0.1% 305
2020
Q4 		$269K Buy
12,216
+4,645
+61% +$96.7K 0.11% 278
2020
Q3 		$157K Sell
7,571
-1,034
-12% -$26.9K 0.08% 313
2020
Q2 		$311K Buy
+8,605
New +$360K 0.15% 296

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Virtus ETF Advisers's APLT Position: Q4 2024 in Review

Virtus ETF Advisers sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 17,524 shares — an estimated $149K sold.

Virtus ETF Advisers first reported a position in APLT in Q2 2020 and held it in 8 quarters. The position peaked at $311K in Q2 2020. 119 funds tracked by Wall St. Rank hold APLT as of Q4 2024.

  • Virtus ETF Advisers reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Virtus ETF Advisers sold 17,524 Applied Therapeutics shares in Q4 2024, an estimated $149K.
  • Virtus ETF Advisers first reported a position in Applied Therapeutics in Q2 2020 and held it in 8 quarters.
  • Virtus ETF Advisers's Applied Therapeutics position peaked at $311K in Q2 2020.
  • 119 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.

Based on Virtus ETF Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.